GNFT.PA Overview
Upcoming Projects (GNFT.PA)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (GNFT.PA)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (GNFT.PA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (GNFT.PA)
-
Genfit (GNFT) Phase 2 program targeting fibrosis and cirrhosis plans to submit IND application in second half of 2017
Tickers: GNFTF, GNFT.PA
Occurred on: Dec 03, 2018 -
Genfit NASH program targeting Nonalcoholic Steatohepatitis with biomarkers plans to begin development in the second half of 2017
Tickers: GNFTF, GNFT.PA
Occurred on: Jan 23, 2018 -
Genfit (GNFT) Phase 2 program targeting fibrosis and cirrhosis plans for preclinical regulatory clearance in third quarter of 2017
Tickers: GNFTF, GNFT.PA
Occurred on: Oct 10, 2017 -
Genfit Phase 2 study testing ELAFIBRANOR (GFT505) in primary biliary cirrhosis (PBC) expecting to enroll first patient in Q2 2017
Tickers: GNFTF, GNFT.PA
Occurred on: May 05, 2017
Strategic Initiatives (GNFT.PA)
-
Don’t see a strategic initiative related to the company you care about? Create your own!